FN2 Earnings Intelligence
Colgate-Palmolive Company earnings overview
Latest Colgate-Palmolive Company (CL) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.
Colgate-Palmolive Company
The quarter supports a mixed but constructive view: resilient demand, emerging-market momentum, premium innovation, and margin execution are positives, while the U.S. recovery and cost volatility remain key tests.
Colgate-Palmolive Company
Colgate-Palmolive beat Q1 2026 estimates with EPS of $0.97 (vs. $0.943 est.) and revenue of $5.32B (vs. $5.22B est.), powered by volume-led organic sales growth in emerging markets, particularly Asia Pacific. Despite lowering gross margin guidance on $300M of assumed raw material and packaging cost inflation (oil at $110/barrel), management maintained overall sales and EPS guidance, pointing to an expanded SGPP savings program ($350-500M, potentially $550M) expected to yield $200-300M in annualized savings beginning largely in 2027-28. North America remained soft but is targeted with brand interventions and new product launches. Hill's pet care posted double-digit premium growth. The stock rose 2.23% on 1.70x baseline volume, with a subsequent drift of +1.34%. Analyst consensus target stands at $96.30 versus a current price of $92.73.
Colgate-Palmolive Company
The call supports a constructive but conditional view: resilient demand, emerging-market momentum, premium innovation, and operational investment provide support, while category growth, consumer uncertainty, foreign exchange, and promotion remain important tests.
Colgate-Palmolive Company
The supplied analysis supports a cautiously constructive operating thesis: brand strength, innovation, pricing tools, and supply-chain flexibility may support resilience, but tariff costs, consumer softness, private-label exit, and commodity inflation remain material offsets.
Colgate-Palmolive Company
The supplied analysis supports a constructive but conditional view: resilient demand, innovation, Hill’s pet nutrition, and margin expansion underpin growth, while FX, tariffs, pricing pressure, and volume risks remain material.
Colgate-Palmolive Company
The supplied analysis supports a constructive operating picture: broad volume growth, margin expansion, premiumization, innovation, and Hill's expansion provide support for continued earnings progress. The thesis remains conditional on pricing discipline, category demand, FX, and competitive dynamics.
Colgate-Palmolive Company
The supplied analysis supports a constructive but qualified view: broad-based volume growth, margin expansion, innovation, and brand investment strengthen the earnings trajectory, while commodity, FX, promotional, and pet-care risks remain relevant.
Get the CL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.